170 related articles for article (PubMed ID: 1975342)
1. Histamine-2-receptor antagonists and gastric cancer risk.
La Vecchia C; Negri E; D'Avanzo B; Franceschi S
Lancet; 1990 Aug; 336(8711):355-7. PubMed ID: 1975342
[TBL] [Abstract][Full Text] [Related]
2. A review of epidemiological studies on cancer in relation to the use of anti-ulcer drugs.
La Vecchia C; Tavani A
Eur J Cancer Prev; 2002 Apr; 11(2):117-23. PubMed ID: 11984128
[TBL] [Abstract][Full Text] [Related]
3. Histamine-2 receptor antagonists and gastric cancer.
Johnson AG; Jick SS; Perera DR; Jick H
Epidemiology; 1996 Jul; 7(4):434-6. PubMed ID: 8793372
[TBL] [Abstract][Full Text] [Related]
4. Histamine-2-receptor antagonists and gastric cancer: update and note on latency and covariates.
La Vecchia C; Negri E; Franceschi S; D'Avanzo B
Nutrition; 1992; 8(3):177-81. PubMed ID: 1356031
[TBL] [Abstract][Full Text] [Related]
5. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.
Møller H; Nissen A; Mosbech J
Gut; 1992 Sep; 33(9):1166-9. PubMed ID: 1358764
[TBL] [Abstract][Full Text] [Related]
6. Histamine-2-receptor antagonists and oesophageal cancer.
Fioretti F; Tavani A; La Vecchia C; Franceschi S
Eur J Cancer Prev; 1997 Apr; 6(2):143-6. PubMed ID: 9237063
[TBL] [Abstract][Full Text] [Related]
7. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists.
Boero M; Pera A; Andriulli A; Ponti V; Canepa G; Palmas F; Duglio A; Molinaro GC; Toselli M; Riccardino N
Digestion; 1983; 28(3):158-63. PubMed ID: 6141973
[TBL] [Abstract][Full Text] [Related]
8. Safety issues relating to long-term treatment with histamine H2-receptor antagonists.
Sabesin SM
Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374
[TBL] [Abstract][Full Text] [Related]
9. Histamine H2-receptor antagonists.
Keithley JK
Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
[TBL] [Abstract][Full Text] [Related]
10. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
11. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
12. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
Tani N; Miwa T
Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
[No Abstract] [Full Text] [Related]
13. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
14. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
15. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
Simon B; Müller P; Dammann HG
Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
[TBL] [Abstract][Full Text] [Related]
16. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
Tamim H; Duranceau A; Chen LQ; Lelorier J
Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
[TBL] [Abstract][Full Text] [Related]
17. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
Domschke W; Domschke S; Demling L
Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical and immunohistological changes in the gastric mucosa of rats with long-term administration of histamine H2-receptor antagonist].
Tsutsumi J; Takayama S; Nimura H
Nihon Shokakibyo Gakkai Zasshi; 1998 Dec; 95(12):1333-42. PubMed ID: 9889541
[TBL] [Abstract][Full Text] [Related]
20. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
